NCT01941225View on ClinicalTrials.gov

Inhaled Iloprost, Dynamic Hyperinflation, and Oxidative Stress in COPD Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Inhaled iloprost 5.0 mcg

Single administration

DRUG

Placebo

Single administration

Trial Locations (1)

70125

LSU Health Sciences Center, New Orleans

All Listed Sponsors
lead

Louisiana State University Health Sciences Center in New Orleans

OTHER

NCT01941225 - Inhaled Iloprost, Dynamic Hyperinflation, and Oxidative Stress in COPD Patients | Biotech Hunter | Biotech Hunter